This editorial essay uses the Ponseti clubfoot method as a case study in disruptive innovation. It asks whether a treatment can improve quality, lower cost, and expand access all at once, defying the Iron Triangle of health economics. Commentaries from Weinstein and Vail debate why such effective innovations are slow to reach practice.
The clinical anchor here is the Ponseti method itself: serial casting for idiopathic clubfoot that produces near-normal alignment and outperforms open surgical release. Know this as the standard of care for congenital clubfoot, first described in 1963 with durable long-term results.
The essay's broader lesson is about evidence adoption. An effective, cheaper method sat underused for decades because scientific information spreads passively, a delay often cited as roughly 17 years for translational research. Weinstein's point is worth carrying: parents finding information online, not surgeons, drove the shift to Ponseti casting.
The alpha-defensin assay for periprosthetic joint infection is presented as a modern parallel, a binary biomarker test that could let non-specialists manage postoperative infection workup and enable regionalized arthroplasty care.
This editorial essay uses the Ponseti clubfoot method as a case study in disruptive innovation. It asks whether a treatment can improve quality, lower cost, and expand access all at once, defying the Iron Triangle of health economics. Commentaries from Weinstein and Vail debate why such effective innovations are slow to reach practice.
The clinical anchor here is the Ponseti method itself: serial casting for idiopathic clubfoot that produces near-normal alignment and outperforms open surgical release. Know this as the standard of care for congenital clubfoot, first described in 1963 with durable long-term results.
The essay's broader lesson is about evidence adoption. An effective, cheaper method sat underused for decades because scientific information spreads passively, a delay often cited as roughly 17 years for translational research. Weinstein's point is worth carrying: parents finding information online, not surgeons, drove the shift to Ponseti casting.
The alpha-defensin assay for periprosthetic joint infection is presented as a modern parallel, a binary biomarker test that could let non-specialists manage postoperative infection workup and enable regionalized arthroplasty care.